Literature DB >> 22581278

A randomized controlled trial of 8-form Tai chi improves symptoms and functional mobility in fibromyalgia patients.

Kim D Jones1, Christy A Sherman, Scott D Mist, James W Carson, Robert M Bennett, Fuzhong Li.   

Abstract

Previous researchers have found that 10-form Tai chi yields symptomatic benefit in patients with fibromyalgia (FM). The purpose of this study was to further investigate earlier findings and add a focus on functional mobility. We conducted a parallel-group randomized controlled trial FM-modified 8-form Yang-style Tai chi program compared to an education control. Participants met in small groups twice weekly for 90 min over 12 weeks. The primary endpoint was symptom reduction and improvement in self-report physical function, as measured by the Fibromyalgia Impact Questionnaire (FIQ), from baseline to 12 weeks. Secondary endpoints included pain severity and interference (Brief Pain Inventory (BPI), sleep (Pittsburg sleep Inventory), self-efficacy, and functional mobility. Of the 101 randomly assigned subjects (mean age 54 years, 93 % female), those in the Tai chi condition compared with the education condition demonstrated clinically and statistically significant improvements in FIQ scores (16.5 vs. 3.1, p = 0.0002), BPI pain severity (1.2 vs. 0.4, p = 0.0008), BPI pain interference (2.1 vs. 0.6, p = 0.0000), sleep (2.0 vs. -0.03, p = 0.0003), and self-efficacy for pain control (9.2 vs. -1.5, p = 0.0001). Functional mobility variables including timed get up and go (-.9 vs. -.3, p = 0.0001), static balance (7.5 vs. -0.3, p    0.0001), and dynamic balance (1.6 vs. 0.3, p = 0.0001) were significantly improved with Tai chi compared with education control. No adverse events were noted. Twelve weeks of Tai chi, practice twice weekly, provided worthwhile improvement in common FM symptoms including pain and physical function including mobility. Tai chi appears to be a safe and an acceptable exercise modality that may be useful as adjunctive therapy in the management of FM patients. (ClinicalTrials.gov Identifier, NCT01311427).

Entities:  

Mesh:

Year:  2012        PMID: 22581278      PMCID: PMC5571653          DOI: 10.1007/s10067-012-1996-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  61 in total

1.  A multistep recruitment strategy to a participant-intensive clinical trial.

Authors:  Kim Dupree Jones; Ann C Reiner
Journal:  Appl Nurs Res       Date:  2009-01-15       Impact factor: 2.257

Review 2.  Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations.

Authors:  Robert H Dworkin; Dennis C Turk; Sarah Peirce-Sandner; Ralf Baron; Nicholas Bellamy; Laurie B Burke; Amy Chappell; Kevin Chartier; Charles S Cleeland; Ann Costello; Penney Cowan; Rozalina Dimitrova; Susan Ellenberg; John T Farrar; Jacqueline A French; Ian Gilron; Sharon Hertz; Alejandro R Jadad; Gary W Jay; Jarkko Kalliomäki; Nathaniel P Katz; Robert D Kerns; Donald C Manning; Michael P McDermott; Patrick J McGrath; Arvind Narayana; Linda Porter; Steve Quessy; Bob A Rappaport; Christine Rauschkolb; Bryce B Reeve; Thomas Rhodes; Cristina Sampaio; David M Simpson; Joseph W Stauffer; Gerold Stucki; Jeffrey Tobias; Richard E White; James Witter
Journal:  Pain       Date:  2010-03-06       Impact factor: 6.961

3.  The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses.

Authors:  R Bennett
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

4.  A randomized trial of tai chi for fibromyalgia.

Authors:  Chenchen Wang; Christopher H Schmid; Ramel Rones; Robert Kalish; Janeth Yinh; Don L Goldenberg; Yoojin Lee; Timothy McAlindon
Journal:  N Engl J Med       Date:  2010-08-19       Impact factor: 91.245

5.  Dealing with change: using the conditional change model for clinical research.

Authors:  Mikel Aickin
Journal:  Perm J       Date:  2009

6.  Physical performance as a predictor of attention and processing speed in fibromyalgia.

Authors:  Barbara J Cherry; Jie Weiss; Brandon K Barakat; Dana N Rutledge; C Jessie Jones
Journal:  Arch Phys Med Rehabil       Date:  2009-12       Impact factor: 3.966

Review 7.  Exercise interventions in fibromyalgia: clinical applications from the evidence.

Authors:  Kim D Jones; Ginevra L Liptan
Journal:  Rheum Dis Clin North Am       Date:  2009-05       Impact factor: 2.670

Review 8.  Exercise for treating fibromyalgia syndrome.

Authors:  A J Busch; K A R Barber; T J Overend; P M J Peloso; C L Schachter
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

9.  Minimal clinically important difference in the fibromyalgia impact questionnaire.

Authors:  Robert M Bennett; Andrew G Bushmakin; Joseph C Cappelleri; Gergana Zlateva; Alesia B Sadosky
Journal:  J Rheumatol       Date:  2009-04-15       Impact factor: 4.666

Review 10.  EULAR evidence-based recommendations for the management of fibromyalgia syndrome.

Authors:  S F Carville; L Arendt-Nielsen; S Arendt-Nielsen; H Bliddal; F Blotman; J C Branco; D Buskila; J A P Da Silva; B Danneskiold-Samsøe; F Dincer; C Henriksson; K G Henriksson; E Kosek; K Longley; G M McCarthy; S Perrot; M Puszczewicz; P Sarzi-Puttini; A Silman; M Späth; E H Choy
Journal:  Ann Rheum Dis       Date:  2007-07-20       Impact factor: 19.103

View more
  31 in total

Review 1.  Deconstructing chronic low back pain in the older adult--Step by step evidence and expert-based recommendations for evaluation and treatment part III: Fibromyalgia syndrome.

Authors:  Gita Fatemi; Meika A Fang; Paula Breuer; Paul E Cherniak; Angela Gentili; Joseph T Hanlon; Jordan F Karp; Natalia E Morone; Eric Rodriguez; Michelle I Rossi; Kenneth Schmader; Debra K Weiner
Journal:  Pain Med       Date:  2015-08-14       Impact factor: 3.750

2.  The degree of cardiac baroreflex involvement during active standing is associated with the quality of life in fibromyalgia patients.

Authors:  Antonio Roberto Zamunér; Alberto Porta; Carolina Pieroni Andrade; Meire Forti; Andrea Marchi; Raffaello Furlan; Franca Barbic; Aparecida Maria Catai; Ester Silva
Journal:  PLoS One       Date:  2017-06-14       Impact factor: 3.240

3.  Seated Tai Chi to alleviate pain and improve quality of life in individuals with spinal cord disorder.

Authors:  Kazuko Shem; Darlene Karasik; Paul Carufel; Ming-Chih Kao; Patricia Zheng
Journal:  J Spinal Cord Med       Date:  2016-03-04       Impact factor: 1.985

Review 4.  Complementary therapies for fibromyalgia syndrome -- a rational approach.

Authors:  Marcelo Saad; Roberta de Medeiros
Journal:  Curr Pain Headache Rep       Date:  2013-08

Review 5.  Role of Tai Chi in the treatment of rheumatologic diseases.

Authors:  Chenchen Wang
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

6.  Tai Chi Improves Sleep Quality in Healthy Adults and Patients with Chronic Conditions: A Systematic Review and Meta-analysis.

Authors:  Gowri Raman; Yuan Zhang; Vincent J Minichiello; Carolyn M D'Ambrosio; Chenchen Wang
Journal:  J Sleep Disord Ther       Date:  2013-09-15

Review 7.  Management of fibromyalgia syndrome in 2016.

Authors:  Akiko Okifuji; Jeff Gao; Christina Bokat; Bradford D Hare
Journal:  Pain Manag       Date:  2016-06-16

Review 8.  Evidence-Based Evaluation of Complementary Health Approaches for Pain Management in the United States.

Authors:  Richard L Nahin; Robin Boineau; Partap S Khalsa; Barbara J Stussman; Wendy J Weber
Journal:  Mayo Clin Proc       Date:  2016-09       Impact factor: 7.616

Review 9.  Resistance exercise training for fibromyalgia.

Authors:  Angela J Busch; Sandra C Webber; Rachel S Richards; Julia Bidonde; Candice L Schachter; Laurel A Schafer; Adrienne Danyliw; Anuradha Sawant; Vanina Dal Bello-Haas; Tamara Rader; Tom J Overend
Journal:  Cochrane Database Syst Rev       Date:  2013-12-20

Review 10.  What do we really know about the safety of tai chi?: A systematic review of adverse event reports in randomized trials.

Authors:  Peter M Wayne; Danielle L Berkowitz; Daniel E Litrownik; Julie E Buring; Gloria Y Yeh
Journal:  Arch Phys Med Rehabil       Date:  2014-05-27       Impact factor: 3.966

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.